Markus Gershater
@markusgershater
Biologist who aspires to engineer. CSO & cofounder @synthace
ID: 163830756
http://www.synthace.com 07-07-2010 11:32:15
1,1K Tweet
1,1K Followers
1,1K Following
Great to see philosophical work on data, metadata & experimentation (incl. Hans Radder’s seminal work), and “data journeys” as explored in European Research Council (ERC) project #DATA SCIENCE, inform the development of intelligent #AI for #biology! Uni of Exeter's Institute for Data Science and AI The Alan Turing Institute #HPS
Has the astounding pace of the COVID #vaccine development set a new expectation for the #therapeutics industry? Our CSO Markus Gershater discusses if we've arrived at a new normal & how we need to apply our learnings to future #DrugDiscovery & development👉synthace.com/covid-vaccine-…
Has the astounding pace of the COVID #vaccine development set a new expectation for the #therapeutics industry? Our CSO Markus Gershater discusses if we've arrived at a new normal & how we need to apply our learnings to future #DrugDiscovery & development👉synthace.com/covid-vaccine-…
Excited to announce in scwmagazine! Check out the post to find out all about our #NoCode cloud platform for #LifeSciences R&D, with insights from our CEO Guy Levy-Yurista. More here👉scientific-computing.com/news/synthace-… #CloudComputing #LabOfTheFuture
.Synthace announced the first #LifeSciences research and development (R&D) #cloud that includes no-code software. By making collaboration and automation easier, Synthace is lowering #accessibility barriers for science. ow.ly/hnvI50FPjWI Guy Levy-Yurista Markus Gershater
BioIndustry Association (BIA) Bioscience Forum 2021 today with: @GeorgeFreemanMP Divya Chadha Manek OBE Indro Mukerjee Innovate UK Vishal Gulati (I back scientists) Tej Panesar Thorben Seeger Lifebit Andreas Ballis Joshua Blight Carlos Luzzani Steve Gardner Markus Gershater Manish Patel JustinWhatling ukbioscienceforum.org/programme.html
Thrilled to announce the launch of a new Alphabet company Isomorphic Labs. Our mission is to reimagine the drug discovery process from first principles with an AI-first approach, to accelerate biomedical breakthroughs and find cures for diseases. Details: isomorphiclabs.com/blog
Exciting News! We've closed our $35M Series C funding led by @Sofinnovavc and Horizons Ventures 🎉 Thanks to our customers, partners, investors, and our amazing team for continuing our Life Sciences R&D cloud mission! ♥️🌍 ➡️ Read Synthace’s story here: hubs.la/H0_hMJL0